Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Augmentation with buspirone: a review

K V Harvey1, R Balon

  • 1Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan, USA.

Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of depression with anti-inflammatory medications-the role of pain relief.

Acta psychiatrica Scandinavica·2019
Same author

Erratum to Richness and Creativity in Medical Student Education in Psychiatry.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2016
Same author

Buprenorphine for the treatment of depression?

Acta psychiatrica Scandinavica·2016
Same author

Politics of self-citation.

Acta psychiatrica Scandinavica·2015
Same author

The moral myopia of academia and "the big chill" of managed care.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Characteristics of directors of medical student education in psychiatry.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same journal

Factors Associated With Severe Mental Illnesses Newly Diagnosed in Perinatal Psychiatric Care: Findings From a Large Clinical Cohort.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2026
Same journal

Protest behaviors among patients placed in seclusion in a psychiatric emergency service.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Problematic internet use and suicidal behavior in adolescents: A review.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Development of a mobile monitoring program for anxiety and depression in pregnancy and evaluation of 3-month results.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Vitamin D levels among adult psychiatric inpatients and the association with psychosis.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Same but different? Phenomenological differences among various types of body-focused repetitive behaviors.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
See all related articles

Buspirone, a serotonin 5-HT 1A partial agonist, shows potential as an adjunctive treatment for various psychiatric disorders. This review explores its efficacy in augmenting other psychotropic medications.

Area of Science:

  • Psychopharmacology
  • Neuroscience

Background:

  • Buspirone is an FDA-approved anxiolytic medication.
  • It functions as a serotonin (5-HT) 1A partial agonist.
  • Investigated for efficacy in depression, panic disorder, OCD, and schizophrenia.

Purpose of the Study:

  • To review existing literature on buspirone's potential as an augmenting agent.
  • To evaluate its utility in combination with other psychotropic medications.

Main Methods:

  • Literature review of clinical trials and studies.
  • Analysis of research supporting buspirone's augmentation role.

Main Results:

  • Several trials suggest buspirone's utility in augmenting psychotropic treatments.

Related Experiment Videos

  • Evidence supports its use across various psychiatric conditions.

    • Conclusions:

    • Buspirone demonstrates promise as an augmenting agent in psychiatric pharmacotherapy.
    • Further research may solidify its role in treatment-resistant cases.